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1. INTRODUCTION
In a cost-effectiveness study of treatments, the focus is often on the average of total
medical costs over a certain time period, say [0, τ ], in a given patient population, where τ
may be five or twenty years. Given the skewed nature of medical cost data, some may argue
for the use of the median instead the mean as the measure of central location. However, in
analyses of medical cost data, only the mean, not the median, can be used to recover the
total medical cost, which reflects the entire expenditure on health care in a given patient
population. In this paper, we focus on making inferences on population means.
Estimating this mean can be complicated by censored cost observations for some patients
who are not followed for the entire time period [0, τ ]. For those censored patients, their true
total costs over [0, τ ] are unknown. By considering costs as potentially right-censored sur-
vival times, several authors have tried to adjust for censoring by using standard survival
techniques. However, Lin et al. [1] have shown this strategy is not valid unless all patients
accrue costs with a common rate function over time and have proposed a non-parametric
consistent estimator for estimating the mean of the total costs under the assumption the
censoring time distribution is discrete. Without making this assumption, Bang and Tsiatis
[2] proposed a simple weighted estimator and established its consistency and asymptotic nor-
mality. Their estimator works well for lightly censored cost data (censoring rate ≤ 30%), but
is quite inefficient for heavily censored data (censoring rate > 40%) since the estimator does
not use any cost information from censored patients. If one can partition [0, τ ] into some
subintervals and if piecewise costs of each patient are available over those subintervals up to
the observed survival time, Bang and Tsiatis [2] also proposed a more efficient partitioned
estimator. Even though asymptotic properties of the partitioned estimator were nicely es-
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tablished, the estimator itself and its asymptotic variance bear some complicated forms.
In Section 2, we simplify the expressions of the partitioned estimator and its asymptotic
variance so that the simplified versions are computationally more straightforward.
As noted before, medical cost observations have a right skewed distribution (Diehr et
al.[3]; Zhou et al. [4]; and Zhou and Tu [5]; Zhou and Tu [6]; and Lumley et al. [7]). In the
simulation studies of Bang and Tsiatis [2] and Lin [1], cost observations were generated from
some mixed uniform distributions and the resulting total costs have an approximately normal
distribution. In this paper we show that confidence intervals based on normal approximations
of Bang and Tsiatis’ estimators can have much lower than nominal level coverage probabilities
when cost observations are moderately or severely skewed. To fix this problem, we propose a
bootstrap confidence interval, and our simulation study show that its coverage probabilities
are close to nominal level coverage probabilities even for small sample sizes. Our paper is
organized as follows. In Section 2 we describe the currently used confidence intervals for
the mean of total medical costs when some patients are censored. In Section 3 we propose
a bootstrap confidence interval for the mean of total medical costs when some patients are
censored. In Section 4 we describe a simulation study for assessing the relative performance
of the new bootstrap interval with the existing intervals. In Section 5 we illustrate the
proposed method in a real study.
2. NOTATION AND ESTIMATORS
Let M(t) denote the random cumulative medical cost of a patient up to time t. Since
no medical costs will be accrued after death, the total cost of a patient incurred in the time
period [0, τ ] is actually M(T ∧ τ), where T is the true survival time of the patient and a∧ b
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denotes the minimum of a and b. Let us introduce some notation for standard survival data.
If we let C denote a random censoring time of the patient, the observed survival time of the
patient is X = T ∧C, and δ = I(T ≤ C) indicates whether the true survival time is observed
or not, where I(.) denotes an indicator function. For a medical cost study, we need to define
another indicator η = I(T ∧ τ ≤ C), which is equal to 1 if the total medical cost accrued
over [0, τ ], M(T ∧ τ), is observed, and 0 if a censored total medical cost, M(C), is observed.
In the standard survival analysis, the censoring time, C, is assumed to be independent of
the true survival time, T . For a medical cost study, we need to make a stronger assumption
than the one in the standard survival analysis. We have to assume that C is independent of
all other random variables in the study; this assumption insures that censoring occurs in a
completely random fashion. If the only reason for the occurrence of censoring is the study
termination, this assumption holds. This type of censoring is referred to as administrative
censoring.
If we do not have the cost history of a patient over time and have only the total cost
for each patient, the observed data can be represented as n independent and identically
distributed realizations of (X, δ, η,M(X)). We can than denote the censored medical cost
data as {(Xi, δi, ηi,Mi), i = 1 . . . n}, where Mi = M(Xi). Let µ = E(M(T ∧ τ)), which is
the true mean of the total cost of a patient over time period [0, τ ]. Let K(.) be the survival
function of the censoring variable C; that is, K(t) = pr(C ≥ t). Bang and Tsiatis [2]
proposed the following simple weighted estimator for µ:
µˆS =
1
n
n∑
i=1
ηiMi
Kˆ(Ti)
, (1)
where Kˆ(.) is the Kaplan-Meier (K-M) estimator for K(.), based on data {(Xi, 1 − δi), i =
1 . . . n}. Bang and Tsiatis [2] have shown that this estimator is consistent and asymptotically
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normally distributed. They have also provided the asymptotic variance for n1/2µˆS, denoted
by (σS)
2, and the corresponding consistent estimator (σˆS)
2.
Assuming that
√
n(µˆS − µ)/σˆS has the standard normal distribution, we may obtain a
(1− α)100% confidence interval for µ as follows:
[µˆS − n−1/2z1−α/2σˆS, µˆS + n−1/2z1−α/2σˆS],
where zp denotes the pth quantile of the standard normal distribution. One drawback of
this estimator is its efficiency when many patients are censored because we only use cost
information from uncensored patients in its calculation.
If we can partition the interval [0, τ ] into L subintervals (tj, tj+1], j = 0, 1, ..., L− 1, and
if the costs incurred in each of these subintervals up to X ∧ τ are available for each patient,
Bang and Tsiatis [2] also proposed the following more efficient estimator of µ:
µˆP =
1
n
n∑
i=1
L∑
j=1
ηjiMij
Kˆj(T
j
i )
. (2)
Here T ji = Ti ∧ tj, ηji = I(T ji ≤ Ci), Mij = Mi(tj) − Mi(tj−1), and Kˆj(.) is the K-M
estimator for the survival function of C, based on the dataset {(Xji , 1 − ηji ), i = 1, ..., n},
where Xji = T
j
i ∧Ci. Let λc(.) denote the hazard function of the censoring random variable
Ci, Sj(u) = pr(T
j
i ≥ u), and
Gj(Ml, u) =
1
Sj(u)
E{MilI(T ji ≥ u)}.
Bang and Tsiatis [2] have shown that n
1
2 (µˆP −µ) has an asymptotically normal distribution
with mean 0 and variance,
σ2P = var(Mi − µ) +∫ τ
0
L∑
j=1
L∑
l=1
Sj∧l(u){Gj∧l(MjMl, u)−Gj∧l(Mj, u)Gj∧l(Ml, u)}λ
c(u)
K(u)
du. (3)
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From (2) and (3), we see that to compute µˆP and its associated variance we need to
compute L times of the estimators Kˆj(.), Sˆj(.), and Gˆj(.), which might result in complexity of
the calculation of variance estimation. In Appendix we show that this partitioned estimator
can be simplified to
µˆP =
1
n
n∑
i=1
L∑
j=1
ηjiMij
Kˆ(T ji )
,
where K(.) is the Kaplan-Meier estimator for the survival function of C based on {(Xi, 1−
δi), i = 1, ..., n}. In this simplified version, we only need to compute one K-M estimator.
Using a different derivation method, we can also show its asymptotic variance can be greatly
simplified for computation. The simplified expressions of σP and σˆP are as follows:
σ2P = var(Mi − µ) +
L∑
j=1
L∑
l=1
∫ tj∧l
0
S(u){G(MjMl, u)−G(Mj, u)G(Ml, u)}λ
c(u)
K(u)
du,
σˆ2P =
1
n
n∑
i=1
ηi(Mi − µˆP )2
Kˆ(Ti)
+
L∑
j=1
L∑
l=1
∫ tj∧l
0
Sˆ(u){Gˆ(MjMl, u)− Gˆ(Mj, u)Gˆ(Ml, u)} dN
c(u)
Y (u)Kˆ(u)
where
Gˆ(Mj, u) =
1
nSˆ(u)
n∑
i=1
ηjiMijI(Ti ≥ u)
Kˆ(T ji )
,
Gˆ(MjMl, u) =
1
nSˆ(u)
n∑
i=1
ηj∨li MijMilI(Ti ≥ u)
Kˆ(T j∨li )
, and j ∨ l = max(j, l).
Thus, instead of computing L functional estimators of Kj’s, Sj’s and Gj’s as in the
original formula for the partitioned estimator and its variance, with the simplified formulas
we only need to compute them once, which eases the computation. Assuming the normality
for
√
n(µˆP − µ)/σˆP , we obtain a (1− α)100% confidence interval for µ as follows:
[µˆP − n−1/2z1−α/2σˆP , µˆP + n−1/2z1−α/2σˆP ].
3. A BOOTSTRAP CONFIDENCE INTERVAL
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Let µˆ and (σˆ)2 be a simple weighted or partitioned estimator for µ and its corresponding
variance estimator, respectively. Although many bootstrap intervals, including Efron’s bias-
corrected accelerated (BCa) bootstrap interval [8], are available for the population mean, it
has been shown that the bootstrap-t interval has the best coverage accuracy in finite sample
sizes (Hall [9]; Shao and Tu [10]). Hence we chose to develop a bootstrap-t interval for µ.
The bootstrap-t interval is based on the bootstrap distribution of the studentized statistics,
T =
√
n(µˆ− µ)/σˆ.
By considering the original data, {(Xi, δi, ηi,Mi), i = 1, . . . , n}, as an independent and
identically distributed (i.i.d.) sample from the joint distribution function for (X, δ, η,M),
we generate our bootstrap samples, by sampling with replacement from {(Xi, δi, ηi,Mi), i =
1, . . . , n}. Let (X∗bi , δ∗bi , η∗bi ,M∗bi ), i = 1, . . . , n, be the bth bootstrap sample, b = 1, . . . , B.
Let µˆ∗b and (σˆ
∗
b )
2 be respectively the values of µˆ and σˆ2 using the bth bootstrap sample. We
calculate the bootstrap version of T as
T ∗b =
√
n
µˆ∗b − µˆ
σˆ∗b
.
Then, a (1− α)% bootstrap-t confidence interval for µ is given by
[µˆ− n−1/2Uσˆ, µˆ− n−1/2Lσˆ],
where L and U are the α/2th and (1− α/2)th quantiles of {T ∗b , b = 1, . . . , B} respectively.
4. NUMERICAL STUDIES
We adopted a similar setup for our simulation study as in Bang and Tsiatis [2] except
that we used skewed distributions for medical costs. The average 10-year cost µ and its 95%
8
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confidence interval are parameters of interest. The survival time T was generated from two
distributions, the uniform distribution over [0, 10 years] and the exponential distribution with
a mean of 5 years. We generated an independent censoring variable C from the two uniform
distributions, one over [0, 20 years] and the other over [0, 12.5 years], which correspond to
light censoring (22% − 25%) and relatively heavy censoring (30% − 40%) on the survival
time within 10 years, respectively. We assumed the true total medical cost of a patient over
[0, T ∧ 10], denoted by M , had a log-normal distribution; that is, logM ∼ N(ρ, σ2), where
ρ = 8 + 1
3
T and where σ was chosen to be either 0.3, 0.5, 0.7 or 1. Under this setup for
the distribution of costs, the expected total medical cost of a patient becomes larger as the
survival time increases, and the cost distribution becomes more skewed as σ increases. The
coefficient of skewness ranged from 1.6 to 8.7 reflecting moderate to severe skewness observed
in medical cost data [3-6]. For computing the partitioned estimator, we divided the 10-year
period into 10 1-year subintervals and the cost incurred in each subinterval up to [0, X ∧ 10]
were obtained according to the cost distribution described above. To construct a bootstrap
confidence interval, we resampled 1000 samples with replacement for each generated dataset.
In all the following tables, the top half corresponds to the simulation results when the
survival time had a uniform distribution, and the bottom half corresponds to the simulation
results when the survival time had an exponential distribution. The first column specifies
the parameter σ of a log-normal distribution we used for generating medical costs, and
the corresponding coefficient of skewness of the cost distribution, β, is listed in the second
column. The third column presents the true expected 10-year total cost µ. In Tables 1-2,
since both the simple weighted and partitioned estimates of µ are more or less unbiased, we
did not report the point estimates in the table. For the comparison purpose, we used two
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methods to construct 95% confidence intervals (C.I.) for µ; the first method uses a normal
approximation for Bang and Tsiatis’ estimators (denoted as “BT” in the table), and the
second method uses the bootstrap method described in Section 3 (denoted as “boot” in the
table). Pcover denotes the coverage probability of the C.I.’s.
Table 1 goes here
All entries in the last eight columns of Table 1 are averages from 1000 simulations with
a fixed sample size of 100 in each setting. The simulation results show that for moderate
sample sizes, the symmetric confidence intervals based on the normal approximation have
coverage probabilities that are much lower than the nominal level when cost distributions
are skewed. The problem is more severe as the degree of skewness increases or censoring
rate increases. In the presence of light censoring, the improvement in efficiency or coverage
accuracy of bootstrap confidence intervals based on the partitioned estimator is minimal
compared to those based on the simple weighted estimator. When the censoring is heavy,
the former has noticeable efficiency advantage than the latter.
Numerical studies were also conducted at larger sample sizes under the above simulation
schemes. Table 2 shows a comparison of the two types of confidence intervals (BT and
boot) based on both the simple weighted and the partitioned estimator in the presence
of heavy censoring with n = 200 or 400. As sample size increases, the performance of
both types of confidence intervals improve, however, the coverage probabilities from the
normal approximation approach are still much lower than the nominal level when the cost
distribution is severely skewed. Overall, the bootstrap confidence interval based on the
partitioned estimator has the superior performance for sample size ≥ 200 and censoring rate
≥ 30%.
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Table 2 goes here
For comparison purpose, we also estimated the mean medical cost for the simulated
skewed medical cost data with censoring using a simple but very useful estimate in medical
cost analysis – mean cost per person-month multiplied by the number of expected follow-up
time on study based on the estimated survival distribution. We refer to this estimator as
the “person-month estimator” for simplicity. The variance of the person-month estimator is
estimated by the empirical variance of the estimates obtained from 1000 bootstrap samples
for each simulated dataset and a 95% confidence interval is constructed using a normal
approximation. In Table 3, we present the relative bias (RB) and coverage probability
(Pcover) of the simple estimator under three censoring schemes: no censoring, light censoring
and heavy censoring. The relative bias is computed using the difference between the average
estimated mean cost and the true mean cost (µ) divided by the true mean cost. In all
settings, the sample size is fixed at 100 and all entries in the last six columns are based on
1000 simulations.
Table 3 goes here
Table 3 shows that the person-month estimate is unbiased when there is no censoring
on the survival time. However, the coverage probability may not be correct when the cost
distribution is severely skewed (β ≥ 4). Since the simulated cost processes have increasing
monthly cost over time, the person-month estimate tends to underestimate the true mean
cost in the presence of censoring and the coverage probabilities of its confidence interval
decrease sharply as the censoring rate increases. In other simulations, we found that as
long as the cost accumulation rate is uniform over time, the unbiasness of the person-month
11
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estimator and the coverage accuracy of its confidence intervals are not affected by the failure
time distribution or the censoring rate. Thus, for censored medical cost data, if the cost
accumulation process is suspected to be non-uniform over time, the simple person-month
estimator is not a good choice, and more complicated methods like the simple weighted or
partitioned estimator should be used.
5. A REAL DATA EXAMPLE
To demonstrate the application of our methodology, we used the same cardiology clinical
trial data as in Bang and Tsiatis [2]. In this trial, 10,948 acute coronary syndrome patients
were randomized to receive either intravenous bolus and 72-hour eptifibatide (i.e. integrilin)
or placebo. The main study objective was to test whether Integrilin could reduce the 30-day
incidence of death and myocardial infarction. A prospective economic sub-study with 2547
patients enrolled was also conducted to compare mean medical costs incurred from initiation
of the treatment until death or six month after the initiation. Since there is no significant
difference in costs across treatments, we use the pooled data to illustrate estimation of
the mean cost with censored observations. As there is up to one year delay in reporting
the six-month medical cost, we use the cost data available at 550 days after study started
to illustrate our methodology and the censoring rate was 48% at that point. Since this
cost-effectiveness study was completed in January 1997, complete cost data for all enrolled
patients are available now. The sample average of the mean cost is $32,596, which can be
considered as the true mean cost and be compared with the estimates we obtained from the
censored medical cost data. As piece-wise costs over time were not available, the partitioned
estimator was not used in estimating the mean medical cost. Simple weighted estimator
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gives an estimate of the mean six-month medical cost as $29,301. The bootstrap confidence
interval for the mean six-month cost based on 5000 resampling is [$25,424, $34,016] while
the confidence interval constructed using normal approximation is [$26,406, $32,195]. Not
surprisingly, the bootstrap confidence interval is wider than the interval based on the normal
approximation, and the former covers the true mean cost ($32,596) while the latter does
not. The result is consistent with our simulation results which showed that the normal
approximation interval has coverage probability that is much lower than the nominal level
while the bootstrap interval has the coverage probability that is close to the nominal level.
On the other hand, the person-month estimator gives an estimate of $40,855 for the mean
six-month medical cost and a confidence interval [$39,236, $42,474]. The person-month
estimator overestimates the true mean because in this dataset, patients with shorter survival
times tend to have higher medical costs.
6. CONCLUSIONS
Cost-effectiveness studies are often conducted in comparing treatments for life threaten-
ing diseases. Mean cost incurred from the start of a treatment till death or certain timepoint
after the implementation of treatment is frequently of interest. In most cases, cost data
may be censored to certain degree due to limited followup time. On the other hand, the
cost accumulation rate over time may depend on disease progression and the survival time,
and hence is non-uniform over time. Thus, the simple person-month estimator is no longer
appropriate and special estimates as proposed by Bang & Tsiatis should be used. In this
article, we simplified the expression of Bang & Tsiatis’ partitioned estimator to make the
computation procedure much easier, and proposed a bootstrap confidence interval for the
13
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mean of medical costs with censored observations instead of the currently available nor-
mal approximation confidence intervals. Numerical studies have shown that the proposed
bootstrap confidence intervals have much better coverage accuracy than the normal approxi-
mation ones when medical costs have a skewed distribution. When there is light censoring on
medical costs (≤ 25%), we have found that the bootstrap confidence intervals based on the
simple weighted estimator is preferred due to its simplicity and good coverage accuracy. For
heavily censored cost data (censoring rate ≥ 30%) with larger sample sizes (n ≥ 200), the
bootstrap confidence intervals based on the partitioned estimator has superior performance
in terms of both efficiency and coverage accuracy.
Our proposed bootstrap sampling was based on one simple sampling plan for a Cox’s
regression model that has been shown to have some good theoretical properties (Shao and Tu
[9]). However, there are other types of bootstrap procedures available for survival data (Burr
[10]), such as the one based on generalized residuals (Shao and Tu [9]) and the one based on
conditional resampling (Davison and Hinkley [11]). It is an interesting future research topic
to study both theoretical and finite-sample properties of these various bootstrap methods
for the analysis of health care costs.
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According to Bang and Tsiatis [2], the partitioned estimator µˆP is as given in (2) and
the asymptotic variance of n
1
2 (µˆP − µ) has following form:
σ2P = var(Mi − µ) + (4)∫ τ
0
L∑
j=1
L∑
l=1
Sj∧l(u){Gj∧l(MjMl, u)−Gj∧l(Mj, u)Gj∧l(Ml, u)}λ
c(u)
K(u)
du.
An estimator of σP is proposed as
σˆ2P =
1
n
n∑
i=1
ηi(Mi − µˆP )2
Kˆ(Ti)
+ (5)
∫ τ
0
L∑
j=1
L∑
l=1
Sˆj∧l(u){Gˆj∧l(MjMl, u)− Gˆj∧l(Mj, u)Gˆj∧l(Ml, u)} dN
c(u)
Y (u)Kˆ(u)
,
where
Gˆj∧l(Ml, u) =
1
nSˆj∧l(u)
n∑
i=1
ηj∨li MilI(T
j∧l
i ≥ u)
Kˆj∨l(T
j∨l
i )
,
Gˆj∧l(MjMl, u) =
1
nSˆj∧l(u)
n∑
i=1
ηj∨li MijMilI(T
j∧l
I ≥ u)
Kˆj∨l(T
j∨l
i )
,
N c(u) =
∑n
i=1 I(Xi ≤ u, δi = 0), Y (u) =
∑n
i=1 I(Xi ≥ u), and Sˆj(.) is the K-M estimator of
Sj(.),
The simplified partitioned estimator is :
µˆP =
1
n
n∑
i=1
L∑
j=1
ηjiMij
Kˆ(T ji )
.
Since it can be shown that
Kˆj(t) =

Kˆ(t) if t ≤ tj
Kˆ(tj) if t > tj
,
and we only need to evaluate Kˆj at T
j
i which does not exceed tj, we can drop the subscript
j from Kˆj and use only one version instead of L versions of functional estimates of K(.) in
the computation.
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Furthermore, we can simplify the expressions in (3) and (5) by noticing that I(tj ≥ u) is
just a constant for any time point u. Hence,
Sj(u) = pr{T ji > u} = pr{Ti > u}I(tj ≥ u) = S(u)I(tj ≥ u)
where S(u) = pr(T > u), and
E{MijI(T ji ≥ u)} = E{MijI(Ti ≥ u)}I(tj ≥ u).
This implies that
Gj(Ml, u) =
1
Sj(u)
E{MilI(T ji ≥ u)}
=
I(tj ≥ u)
S(u)
E{MilI(Ti ≥ u)} ≡ G(Ml, u)I(tj ≥ u).
The simplified expressions of σP and σˆP are as follows:
σP = var(Mi − µ) +
L∑
j=1
L∑
l=1
∫ tj∧l
0
S(u){G(MjMl, u)−G(Mj, u)G(Ml, u)}λ
c(u)
K(u)
du,
σˆP =
1
n
n∑
i=1
ηi(Mi − µˆP )2
Kˆ(Ti)
+
K∑
j=1
K∑
l=1
∫ tj∧l
0
Sˆ(u){Gˆ(MjMl, u)− Gˆ(Mj, u)Gˆ(Ml, u)} dN
c(u)
Y (u)Kˆ(u)
where
Gˆ(Mj, u) =
1
nSˆ(u)
n∑
i=1
ηjiMijI(Ti ≥ u)
Kˆ(T ji )
and
Gˆ(MjMl, u) =
1
nSˆ(u)
n∑
i=1
ηj∨li MijMilI(Ti ≥ u)
Kˆ(T j∨li )
.
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Table 1: Simulation results for bootstrap and BT confidence intervals (n=100)
Light Censoring Heavy Censoring
C.I. width 100 ∗ Pcover C.I. width 100 ∗ Pcover
σ β µ BT boot BT boot BT boot BT boot
Uniform survival distribution
0.3 1.64 25287
Simple weighted estimate 11240 12719 93.5 95.7 12899 18544 89.0 93.4
Partitioned estimate 10949 12150 94.0 95.8 12001 15213 91.0 93.8
0.5 2.60 27393
Simple weighted estimate 14223 16992 90.9 93.2 16980 27179 85.8 93.2
Partitioned estimate 13713 16192 92.3 94.7 14975 20546 89.4 93.0
0.7 4.20 30885
Simple weighted estimate 19310 25634 89.6 92.2 23283 44121 84.0 92.4
Partitioned estimate 18274 23511 90.6 92.3 19628 30075 86.5 92.9
1 7.87 39856
Simple weighted estimate 34660 559331 85.6 91.7 40176 96377 80.4 89.9
Partitioned estimate 31628 52694 88.0 93.5 32089 58407 82.3 91.3
Exponential survival distribution
0.3 1.87 24896
Simple weighted estimate 14133 16365 93.8 95.8 16274 38301 86.1 95.3
Partitioned estimate 13859 15831 91.6 94.7 15220 22919 90.5 92.8
0.5 2.84 26970
Simple weighted estimate 17673 22379 90.2 94.5 20834 54970 83.6 93.5
Partitioned estimate 16980 20864 91.4 93.8 18698 30610 86.9 89.7
0.7 4.55 30408
Simple weighted estimate 23576 34009 88.4 94.6 28005 92673 80.3 92.3
Partitioned estimate 21779 30030 89.0 94.2 23500 47899 83.1 93.2
1 8.72 39240
Simple weighted estimate 39148 73360 84.0 92.3 47460 215131 75.3 88.9
Partitioned estimate 36477 65231 84.2 90.9 37398 86788 77.9 88.3
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Table 2: Simulation results for bootstrap and BT confidence intervals under heavy censoring
n = 200 n = 400
C.I. width 100 ∗ Pcover C.I. width 100 ∗ Pcover
σ β µ BT boot BT boot BT boot BT boot
Uniform survival distribution
0.3 1.64 25287
Simple weighted estimate 9449 11361 91.3 94.0 6799 7384 93.0 93.8
Partitioned estimate 8784 9861 92.7 95.2 6305 6650 93.5 94.5
0.5 2.60 27393
Simple weighted estimate 12697 16424 89.4 92.3 9222 10576 93.6 93.8
Partitioned estimate 11074 13128 91.6 93.2 7993 8771 94.1 94.3
0.7 4.20 30885
Simple weighted estimate 17534 24580 88.7 93.2 13243 16460 91.2 94.8
Partitioned estimate 14689 18698 90.0 93.4 10901 12660 92.4 94.6
1 7.87 39856
Simple weighted estimate 31007 53530 85.0 91.4 24241 35787 88.0 90.9
Partitioned estimate 25347 38389 86.7 93.3 19273 25619 89.2 92.7
Exponential survival distribution
0.3 1.87 24896
Simple weighted estimate 12079 16667 93.0 96.3 8753 9408 93.6 93.8
Partitioned estimate 11133 13160 93.3 95.9 8017 8452 94.4 94.5
0.5 2.84 26970
Simple weighted estimate 16091 25994 88.0 93.6 11798 13829 93.2 94.6
Partitioned estimate 13700 17564 90.2 93.0 9978 11090 93.0 93.7
0.7 4.55 30408
Simple weighted estimate 22610 42025 86.7 93.3 16981 22730 91.0 94.2
Partitioned estimate 18329 26470 89.3 93.5 13559 16576 91.8 94.4
1 8.72 39240
Simple weighted estimate 37738 88373 82.2 91.2 30418 50353 86.7 91.5
Partitioned estimate 29737 52229 85.8 92.3 23251 33599 88.1 92.7
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Table 3: Simulation results for person-month estimate
no censoring light censoring heavy censoring
σ β µ 100 ∗ RB 100 ∗ Pcover 100 ∗ RB 100 ∗ Pcover 100 ∗ RB 100 ∗ Pcover
Uniform survival distribution
0.3 1.64 25287 0.2 93.1 -8.4 80.7 -15.6 55.6
0.5 2.60 27393 0.3 93.9 -8.7 79.5 -15.1 60.9
0.7 4.20 30885 0.2 92.0 -9.3 78.5 -15.5 64.0
1 7.87 39856 0.1 89.3 -8.0 77.4 -14.6 66.6
Exponential survival distribution
0.3 1.87 24896 0.3 94.2 -10.8 78.6 -20.4 51.1
0.5 2.84 26970 0.4 93.3 -11.5 77.6 -20.4 53.7
0.7 4.55 30408 -1.3 89.5 -11.7 75.4 -21.5 54.8
1 8.72 39240 0.5 88.4 -10.5 73.9 -19.9 60.2
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